<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02927626</url>
  </required_header>
  <id_info>
    <org_study_id>BeijingDH</org_study_id>
    <nct_id>NCT02927626</nct_id>
  </id_info>
  <brief_title>Yang Yin Fu Zheng Therapy in HBV Associated Hepatocellular Carcinoma</brief_title>
  <acronym>YYFZTIHBVHCC</acronym>
  <official_title>Clinical Research of Yang Yin Fu Zheng Therapy in HBV Associated Hepatocellular Carcinoma Basing on Immune Microenviroment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Ditan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Ditan Hospital</source>
  <brief_summary>
    <textblock>
      Clinical research of Yang Yin Fu Zheng therapy in HBV associated hepatocellular carcinoma
      basing on immune microenviroment.The purpose of this study is to observe the efficacy of
      routine medical care combined with Yang Yin Fu Zheng therapy for patients belong to HBV-HCC.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2016</start_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Survival rate</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Objective response rate</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of life(QOL)</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">132</enrollment>
  <condition>Hepatocellular Carcinoma</condition>
  <arm_group>
    <arm_group_label>Yang Yin Fu Zheng therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Routine medical care</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Yang Yin Fu Zheng therapy</intervention_name>
    <description>Yang Yin Fu Zheng is a Chinese herbal compound.</description>
    <arm_group_label>Yang Yin Fu Zheng therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Routine medical care</intervention_name>
    <description>Routine medical care</description>
    <arm_group_label>Yang Yin Fu Zheng therapy</arm_group_label>
    <arm_group_label>Routine medical care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Confirmed of stage HBV-HCCⅡb、Ⅲa、Ⅲb;

          2. Ages Eligible for Study: ≤75 years old;

          3. TCM syndrome is deficiency of both Qi and Yin;

          4. Confirmed of CHB;

          5. Surgery cannot be allowed;

          6. Informed consent from the patient.

        Exclusion Criteria:

          1. Patient with other chronic hepatopathy, such as AIH, NAFLD, ALD;

          2. Serious problem of heart, lung, or kidney with severe dysfunction;

          3. Pregnant or child breast feeding women;

          4. Mental or cognitive disorders;

          5. Participating in other drug trials;

          6. Who are allergic to the study drug.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhiyun Yang, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Ditan Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zhiyun Yang, PhD</last_name>
    <phone>+8613439696988</phone>
    <email>13439696988@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Zhiyun Yang</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100013</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhiyun , Yang</last_name>
      <phone>+8613439696988</phone>
      <email>13439696988@163.com</email>
    </contact>
    <investigator>
      <last_name>Zhiyun Yang, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 6, 2016</study_first_submitted>
  <study_first_submitted_qc>October 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 7, 2016</study_first_posted>
  <last_update_submitted>October 6, 2016</last_update_submitted>
  <last_update_submitted_qc>October 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Ditan Hospital</investigator_affiliation>
    <investigator_full_name>Zhiyun Yang</investigator_full_name>
    <investigator_title>archiater,professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

